Individual identification of 32 genotypes. One genotype = one probe line. ...
Design based on E7 target region: Overcomes potential false-negative resu...
Method: Isothermal amplification with real time fluorescence detection ...
Method: Isothermal amplification with real time fluorescence detection ...
Fujirebio is global R&D-driven company constantly developing new in vitro diagnostics testing technologies and unique biomarkers with high clinical value. Our group mission is to create new value in healthcare and thereby contribute to human health and the future of medical care. Our global teams located in Japan, Asia, Europe, and the US focus on delivering products with the highest quality standards to our customers and partners. We value CDMO partnerships with many of the world’s leading diagnostic companies, sharing knowledge, capabilities, and critical materials to supply, develop, or manufacture diagnostic solutions on a wide variety of platforms.